CGAS and neoplasm: Across the different stages of tumor progression from primary tumor to metastasis, the administration of STING agonists could be either beneficial or further stimulate tumor growth.[11, 33] In the early stages of tumor development, DNA damage can lead to MN formation, activating the cGAS‐STING pathway.